Literature DB >> 12517871

Rapid enterovirus RNA detection in clinical specimens by using nucleic acid sequence-based amplification.

Marie L Landry1, Robin Garner, David Ferguson.   

Abstract

Enterovirus (EV) detection by nucleic acid sequence-based amplification was compared with EV isolation in cell culture. The NucliSens Basic kit (bioMerieux) was utilized for RNA detection. For virus isolation, samples were inoculated into MRC-5, primary rhesus monkey kidney, A549, rhabdomyosarcoma, and/or Buffalo green monkey kidney cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12517871      PMCID: PMC149595          DOI: 10.1128/JCM.41.1.346-350.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Detection of precytopathic effect of enteroviruses in clinical specimens by centrifugation-enhanced antigen detection.

Authors:  S M Lipson; K David; F Shaikh; L Qian
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

2.  Rapid and simple method for purification of nucleic acids.

Authors:  R Boom; C J Sol; M M Salimans; C L Jansen; P M Wertheim-van Dillen; J van der Noordaa
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

3.  Comparison of rhabdomyosarcoma, buffalo green monkey kidney epithelial, A549 (human lung epithelial) cells and human embryonic lung fibroblasts for isolation of enteroviruses from clinical samples.

Authors:  T W Kok; T Pryor; L Payne
Journal:  J Clin Virol       Date:  1998-07-24       Impact factor: 3.168

Review 4.  Parechoviruses, a novel group of human picornaviruses.

Authors:  P Joki-Korpela; T Hyypiä
Journal:  Ann Med       Date:  2001-10       Impact factor: 4.709

Review 5.  Reverse-transcription polymerase chain reaction detection of the enteroviruses.

Authors:  J R Romero
Journal:  Arch Pathol Lab Med       Date:  1999-12       Impact factor: 5.534

6.  Development and evaluation of nucleic acid sequence based amplification (NASBA) for diagnosis of enterovirus infections using the NucliSens Basic Kit.

Authors:  Julie D Fox; Song Han; Agneta Samuelson; Yadan Zhang; M Lynne Neale; Diana Westmoreland
Journal:  J Clin Virol       Date:  2002-02       Impact factor: 3.168

7.  Diagnosis of enteroviral meningitis by using PCR with a colorimetric microwell detection assay.

Authors:  H A Rotbart; M H Sawyer; S Fast; C Lewinski; N Murphy; E F Keyser; J Spadoro; S Y Kao; M Loeffelholz
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

8.  A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes.

Authors:  B van Gemen; R van Beuningen; A Nabbe; D van Strijp; S Jurriaans; P Lens; T Kievits
Journal:  J Virol Methods       Date:  1994-09       Impact factor: 2.014

9.  Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management.

Authors:  C Ramers; G Billman; M Hartin; S Ho; M H Sawyer
Journal:  JAMA       Date:  2000 May 24-31       Impact factor: 56.272

10.  Treatment of potentially life-threatening enterovirus infections with pleconaril.

Authors:  H A Rotbart; A D Webster
Journal:  Clin Infect Dis       Date:  2001-01-15       Impact factor: 9.079

View more
  14 in total

1.  Comparison of the NucliSens Basic kit (Nucleic Acid Sequence-Based Amplification) and the Argene Biosoft Enterovirus Consensus Reverse Transcription-PCR assays for rapid detection of enterovirus RNA in clinical specimens.

Authors:  Marie L Landry; Robin Garner; David Ferguson
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

2.  Development, technical performance, and clinical evaluation of a NucliSens basic kit application for detection of enterovirus RNA in cerebrospinal fluid.

Authors:  Christine C Ginocchio; Frank Zhang; Amisha Malhotra; Ryhana Manji; Peter Sillekens; Helma Foolen; Marlieke Overdyk; Margot Peeters
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

3.  Real-time nucleic acid sequence-based amplification using molecular beacons for detection of enterovirus RNA in clinical specimens.

Authors:  Marie L Landry; Robin Garner; David Ferguson
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

4.  Isolation and detection of enterovirus RNA from large-volume water samples by using the NucliSens miniMAG system and real-time nucleic acid sequence-based amplification.

Authors:  Saskia A Rutjes; Ronald Italiaander; Harold H J L van den Berg; Willemijn J Lodder; Ana Maria de Roda Husman
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

Review 5.  Role of cell culture for virus detection in the age of technology.

Authors:  Diane S Leland; Christine C Ginocchio
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

6.  Evaluation of LightCycler as a platform for nucleic acid sequence-based amplification (NASBA) in real-time detection of enteroviruses.

Authors:  Anna-Maria Costa; David Lamb; Suzanne M Garland; Sepehr N Tabrizi
Journal:  Curr Microbiol       Date:  2007-10-02       Impact factor: 2.188

7.  Comparison of cell culture with RT-PCR for enterovirus detection in stool specimens from patients with acute flaccid paralysis.

Authors:  Zabih-Ollah Shoja; Hamideh Tabatabie; Shohreh Shahmahmoudi; Rakhshandeh Nategh
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

8.  Biographical Feature: Marie-Louise Landry, M.D.

Authors:  Yi-Wei Tang
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

9.  Comparison of SmartCycler real-time reverse transcription-PCR assay in a public health laboratory with direct immunofluorescence and cell culture assays in a medical center for detection of influenza A virus.

Authors:  Nadia F Habib-Bein; William H Beckwith; Donald Mayo; Marie L Landry
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

10.  Nonsusceptibility of primate cells to Taura syndrome virus.

Authors:  Carlos R Pantoja; Solangel A Navarro; Jaime Naranjo; Donald V Lightner; Charles P Gerba
Journal:  Emerg Infect Dis       Date:  2004-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.